 |
市場調査レポート
体外診断 (IVD) の世界市場に対する新型コロナウイルス感染症 (Covid-19) の影響：技術別 (PCR、NGS、ELISA、迅速検査、血液検査、止血検査、臨床化学、微生物検査、尿検査)・エンドユーザー別・地域別の将来予測 (2025年まで)COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025 |
||||||
| 発行 | MarketsandMarkets | 商品コード | 936015 | ||||
| 出版日 | ページ情報 | 英文 93 Pages  |
|||||
| 価格 |
|
||||||
| 体外診断 (IVD) の世界市場に対する新型コロナウイルス感染症 (Covid-19) の影響：技術別 (PCR、NGS、ELISA、迅速検査、血液検査、止血検査、臨床化学、微生物検査、尿検査)・エンドユーザー別・地域別の将来予測 (2025年まで) COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025 | ||
| 出版日: 2020年05月06日 | ページ情報: 英文 93 Pages |
|
世界の体外診断 (IVD) の市場規模は、2020年には610億米ドルに達し、さらに2020?2025年に6.5%のCAGRで成長すると、予測されています。Covid-19の感染拡大に伴い、各種診断薬の需要が増大し、また各企業も生産・流通体制の強化に乗り出しています。技術別ではPCR検査が、地域別では北米諸国が最大のシェアを占めています。
当レポートでは、世界の体外診断市場の現状・将来展望や、新型コロナウイルス感染症 (Covid-19) に伴う影響について分析し、市場の基本構造や規制環境、全体的な市場規模の動向見通し、技術別・エンドユーザー別・地域別の詳細動向、市場競争環境 (主要企業の資本取引・事業展開状況) 、といった情報を取りまとめてお届けいたします。
"The global in-vitro diagnostics market is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025."
The global in-vitro diagnostics market size is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025. The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to increase mainly due to factors such as a sharp rise in market demand for PCR, NGS, serology based rapid-test products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities as well as to focus on product commercialization & upgrades. The in-vitro diagnostics market is segmented on technology, end user, and region/country.
Based on technology, the in-vitro diagnostics market is segmented into PCR, NGS, ELISA, Rapid-tests, clinical chemistry, hematology, hemostasis, urinalysis, microbiology testing, and others. The PCR segment is expected to hold the largest share of the global in-vitro diagnostics industry in 2020 - H1. Factors such as the increasing patient emphasis on effective & early patient screening, continued commercialization of novel COVID screening platforms by major players, early efforts of key players to address supply chain bottlenecks, and easy availability of controls & standards are driving the growth of this segment.
The US is expected to account for the largest share of the in-vitro diagnostics market in 2020 - H1, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative diagnostic products coupled with ongoing advancements in the field of gene & immunoassay based products, the recent discovery of genetic biomarkers & their clinical role in immunoassay testing, supportive government policies & their emphasis on novel product development, and the significant expansion of target patient population.
As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
This report studies the in-vitro diagnostics market based on technology, end user, and region/country. It studies major factors (such as drivers and restraints) affecting the market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for global leaders. It analyzes micromarkets with respect to individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.
This report focuses on various levels of analysis - industry trends, COVID impact on major technologies, market shares of major global players, which together form basic views. It also analyzes the competitive landscape; major & emerging segments of the in-vitro diagnostics market; and high-growth geographies and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
